HSP90B1 and systemic lupus erythematosus: For instance, in an SLE mouse model, it was observed that chemical treatment targeting the surface translocation of gp96 diminished and alleviated SLE-associated manifestations, like glomerulonephritis, proteinuria, and levels of antinuclear and DNA antibodies.